"Hypercholesterolemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
| Descriptor ID |
D006937
|
| MeSH Number(s) |
C18.452.584.500.500.396
|
| Concept/Terms |
Hypercholesterolemia- Hypercholesterolemia
- Hypercholesterolemias
- High Cholesterol Levels
- Cholesterol Level, High
- Cholesterol Levels, High
- High Cholesterol Level
- Level, High Cholesterol
- Levels, High Cholesterol
- Elevated Cholesterol
- Cholesterol, Elevated
- Cholesterols, Elevated
- Elevated Cholesterols
- Hypercholesteremia
- Hypercholesteremias
|
Below are MeSH descriptors whose meaning is more general than "Hypercholesterolemia".
Below are MeSH descriptors whose meaning is more specific than "Hypercholesterolemia".
This graph shows the total number of publications written about "Hypercholesterolemia" by people in this website by year, and whether "Hypercholesterolemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 1 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 2 | 1 | 3 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 5 | 1 | 6 |
| 2003 | 3 | 5 | 8 |
| 2004 | 4 | 1 | 5 |
| 2005 | 2 | 2 | 4 |
| 2006 | 2 | 2 | 4 |
| 2007 | 0 | 1 | 1 |
| 2008 | 3 | 4 | 7 |
| 2010 | 3 | 0 | 3 |
| 2011 | 2 | 0 | 2 |
| 2012 | 4 | 0 | 4 |
| 2013 | 4 | 0 | 4 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 2 | 3 |
| 2017 | 0 | 1 | 1 |
| 2018 | 3 | 1 | 4 |
| 2019 | 6 | 1 | 7 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypercholesterolemia" by people in Profiles.
-
Gidding SS. Addressing Knowledge Gaps in the Primary Prevention of Atherosclerotic Heart Disease. J Am Heart Assoc. 2024 Mar 19; 13(6):e033991.
-
Berry ASF, Jones LK, Sijbrands EJ, Gidding SS, Oetjens MT. Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery Disease. Arterioscler Thromb Vasc Biol. 2023 10; 43(10):2058-2067.
-
Gidding SS, Kirchner HL, Brangan A, Howard W, Kelly MA, Myers KD, Morgan KM, Oetjens MT, Shuey TC, Staszak D, Strande NT, Walters NL, Yu KD, Wilemon KA, Williams MS, Sturm AC, Jones LK. Yield of Familial Hypercholesterolemia Genetic and Phenotypic Diagnoses After Electronic Health Record and Genomic Data Screening. J Am Heart Assoc. 2023 07 04; 12(13):e030073.
-
Jones LK, Tilberry S, Gregor C, Yaeger LH, Hu Y, Sturm AC, Seaton TL, Waltz TJ, Rahm AK, Goldberg A, Brownson RC, Gidding SS, Williams MS, Gionfriddo MR. Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis. Implement Sci. 2021 04 13; 16(1):40.
-
Landmesser U, Poller W, Tsimikas S, Most P, Paneni F, L?scher TF. From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases. Eur Heart J. 2020 10 21; 41(40):3884-3899.
-
Weintraub WS, Arbab-Zadeh A. Should We Adjust Low-Density Lipoprotein Cholesterol Management to the Severity of Coronary Artery Disease? JACC Cardiovasc Imaging. 2020 09; 13(9):1973-1975.
-
Gidding SS, Wilemon K, Chugh S. Familial Hypercholesterolemia Causes Sudden Death. J Am Coll Cardiol. 2019 12 10; 74(23):2951-2952.
-
Skolnik N. Treating Hypercholesterolemia in Older Adults-Reply. JAMA. 2019 08 20; 322(7):695-696.
-
Myers KD, Farboodi N, Mwamburi M, Howard W, Staszak D, Gidding S, Baum SJ, Wilemon K, Rader DJ. Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes. Circ Cardiovasc Qual Outcomes. 2019 08; 12(8):e005404.
-
Jones LK, Gidding SS, Seaton TL, Goldberg A, Gregor C, Sturm AC, Brownson RC, Rahm AK, Williams MS. Developing implementation strategies to improve uptake of guideline-recommended treatments for individuals with familial hypercholesterolemia: A protocol. Res Social Adm Pharm. 2020 03; 16(3):390-395.